Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paragon 28 (FNA)
NYSE:FNA
FNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.65 - $13.76
Previous CloseN/A
Volume85.39K
Average Volume (3M)1.80M
Market Cap
$1.10B
Enterprise Value$629.66M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Feb 27, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.88
Shares Outstanding83,860,535
10 Day Avg. Volume1,060,824
30 Day Avg. Volume1,798,821
Standard Deviation0.20
R-Squared0.14
Alpha-0.00858
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.45
Price to Cash Flow (P/CF)-102.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.83
Enterprise Value/Ebitda-23.26
Forecast
1Y Price Target
$13.00Price Target Upside-0.38% Downside
Rating ConsensusHold
Number of Analyst Covering5
---
Paragon 28 News
---
Bulls Say, Bears Say
Bulls Say
AcquisitionZBH and FNA announced they entered into a definitive agreement for ZBH to acquire all outstanding shares of FNA in a transaction valued at ~$1.2B.
Product InnovationParagon 28's culture of stressing innovation, its focused sales organization, and its broad product portfolio make it well positioned to benefit from F&A segment characteristics such as surgeon emphasis on quality reps and continued innovation.
Revenue GrowthParagon 28 reported preliminary Q4/24 revenue of $71.5M-$71.8M, an increase of 18.0-18.5% Y/Y, compared to CG/consensus estimates of $69.6M/$69.6M.
Bears Say
Analyst RecommendationFollowing shares moving to the deal price, the recommendation for shares is downgraded to EW-Vol. from OW-Vol.
Deal ValuationThe deal price is lower than expected.
Market ShareBoth companies' market shares are low in the $5B foot & ankle market.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FNA FAQ
What was Paragon 28’s price range in the past 12 months?
Paragon 28 lowest stock price was $4.65 and its highest was $13.76 in the past 12 months.
What is Paragon 28’s market cap?
Paragon 28’s market cap is $1.10B.
When is Paragon 28’s upcoming earnings report date?
Paragon 28’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were Paragon 28’s earnings last quarter?
Paragon 28 released its earnings results on Nov 12, 2024. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.156 by $0.006.
Is Paragon 28 overvalued?
According to Wall Street analysts Paragon 28’s price is currently Overvalued.
Does Paragon 28 pay dividends?
Paragon 28 does not currently pay dividends.
What is Paragon 28’s EPS estimate?
Paragon 28’s EPS estimate is -0.12.
How many shares outstanding does Paragon 28 have?
Paragon 28 has 83,860,535 shares outstanding.
What happened to Paragon 28’s price movement after its last earnings report?
Paragon 28 reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.156. Following the earnings report the stock price went up 37.333%.
Which hedge fund is a major shareholder of Paragon 28?
Currently, no hedge funds are holding shares in FNA
---
Paragon 28 Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.00 (-0.38% Downside)
$13.00 (-0.38% Downside)
Hedge Fund Trend
Decreased
By 12.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.59%
12-Months-Change
Fundamentals
Return on Equity
-43.68%
Trailing 12-Months
Asset Growth
2.95%
Trailing 12-Months
Company Description
Paragon 28
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, charcot, fracture fixation, hallux valgus, hammertoe, and flatfoot.
---
FNA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Paragon 28's Q3 2024 highlighted strong financial performance with record revenues, successful product launches, improved adjusted EBITDA, and increased revenue guidance. Despite slight decreases in gross margin and non-recurring severance costs, the company's overall performance and strategic initiatives for sustainable growth and efficiency suggest a positive outlook.Read More>---
FNA Stock 12 Month Forecast
Average Price Target
$13.00
▼(-0.38% Downside)
Technical Analysis
Best Analysts Covering FNA
1 Year
1 Year Success Rate
8/18 ratings generated profit
1 Year Average Return
-4.61%
reiterated a buy rating 3 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of -4.61% per trade.
---